CN103998423B - 曲伏前列素的制备方法 - Google Patents

曲伏前列素的制备方法 Download PDF

Info

Publication number
CN103998423B
CN103998423B CN201280063528.2A CN201280063528A CN103998423B CN 103998423 B CN103998423 B CN 103998423B CN 201280063528 A CN201280063528 A CN 201280063528A CN 103998423 B CN103998423 B CN 103998423B
Authority
CN
China
Prior art keywords
formula
compound
carried out
travoprost
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280063528.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN103998423A (zh
Inventor
Z.卡多斯
T.基斯
I.拉兹洛菲
I.霍托巴格伊
Z.比肖夫
A.伯蒂斯
G.哈瓦西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kinoin Medicine And Private Of Chemical Plant LP
Original Assignee
Kinoin Medicine And Private Of Chemical Plant LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinoin Medicine And Private Of Chemical Plant LP filed Critical Kinoin Medicine And Private Of Chemical Plant LP
Publication of CN103998423A publication Critical patent/CN103998423A/zh
Application granted granted Critical
Publication of CN103998423B publication Critical patent/CN103998423B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
CN201280063528.2A 2011-12-21 2012-12-10 曲伏前列素的制备方法 Active CN103998423B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP1100701 2011-12-21
HU1100701A HU231203B1 (hu) 2011-12-21 2011-12-21 Új eljárás travoprost előállítására
PCT/HU2012/000132 WO2013093528A1 (en) 2011-12-21 2012-12-10 Process for the preparation of travoprost

Publications (2)

Publication Number Publication Date
CN103998423A CN103998423A (zh) 2014-08-20
CN103998423B true CN103998423B (zh) 2018-04-27

Family

ID=89990547

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280063528.2A Active CN103998423B (zh) 2011-12-21 2012-12-10 曲伏前列素的制备方法

Country Status (18)

Country Link
US (2) US9212125B2 (enExample)
EP (1) EP2802562B1 (enExample)
JP (1) JP6174040B2 (enExample)
KR (1) KR102027889B1 (enExample)
CN (1) CN103998423B (enExample)
BR (1) BR112014014060A2 (enExample)
CA (1) CA2859923C (enExample)
ES (1) ES2721662T3 (enExample)
HU (1) HU231203B1 (enExample)
IL (1) IL232625B (enExample)
IN (1) IN2014CN03482A (enExample)
MX (1) MX2014007684A (enExample)
PL (1) PL2802562T3 (enExample)
RU (1) RU2631316C2 (enExample)
TR (1) TR201905687T4 (enExample)
TW (1) TWI640500B (enExample)
WO (1) WO2013093528A1 (enExample)
ZA (1) ZA201404440B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2723714T3 (pl) * 2011-06-02 2018-02-28 CHINOIN Zrt. Nowe sposoby otrzymywania amidów prostaglandyn
US9115109B2 (en) 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
HU231214B1 (hu) * 2014-03-13 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás nagytisztaságú prosztaglandinok előállítására
US11458041B2 (en) 2015-10-08 2022-10-04 Ocular Therapeutix, Inc. Punctal plug and bioadhesives
EP3950672A4 (en) * 2019-03-27 2023-01-11 Kyowa Pharma Chemical Co., Ltd. PROCESS FOR PRODUCTION OF PROSTAGLANDIN
HU231350B1 (hu) * 2019-12-18 2023-01-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt Eljárás királis prosztaglandin-enol intermedier előállítására, és az eljárásban hasznos köztitermék vegyületek
CA3166738A1 (en) 2020-02-06 2021-08-12 Charles D. Blizzard Travoprost compositions and methods for treating ocular diseases
CA3177005A1 (en) 2020-04-27 2021-11-04 Michael Goldstein Methods of treating allergic conjunctivitis
WO2022138586A1 (ja) * 2020-12-23 2022-06-30 協和ファーマケミカル株式会社 幾何異性体の分離方法
CN114671906B (zh) * 2020-12-24 2024-03-15 武汉武药制药有限公司 制备曲伏前列素中间体的方法
CN116947725A (zh) * 2022-04-14 2023-10-27 广州楷石医药有限公司 曲伏前列素的合成方法
CN115806517A (zh) * 2022-12-21 2023-03-17 上海彩迩文生化科技有限公司 一种高纯度地诺前列腺素的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1533385A (zh) * 2001-05-24 2004-09-29 Ӣ��ʯ�ͻ�ѧƷ���޹�˾ 前列腺素及其类似物的制备方法
EP2143712A1 (en) * 2008-07-10 2010-01-13 Sandoz AG Improved Process for the Production of Prostaglandins and Prostaglandin Analogs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2328131C3 (de) * 1973-05-30 1986-11-13 Schering AG, 1000 Berlin und 4709 Bergkamen Neues Verfahren zur Herstellung von Prostaglandin-F↓2↓↓α↓ und seinen Analogen
HU184948B (en) * 1981-04-14 1984-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 5-substituted 4-oxo-pgi down 1 derivatives
HU190007B (en) 1982-05-06 1986-08-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing new aromatic prostacylin analogues
CS239696B1 (cs) * 1984-05-03 1986-01-16 Jiri Hajek Způsob dělení 15S-a 15R-isomerů 4-/4-/substituovaných X-fenoxy/-3-hydroxy-1butenyí/hexahydro-5-hydroxy- -2H-cyklopenta[b]furan-2-onů
HU212570B (en) * 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US7166730B2 (en) * 2000-01-27 2007-01-23 Fine Tech Laboratories, Ltd Process for the preparation of prostaglandin derivatives
GB0329379D0 (en) * 2003-12-19 2004-01-21 Johnson Matthey Plc Prostaglandin synthesis
KR100850133B1 (ko) * 2004-01-05 2008-08-04 니콕스 에스. 에이. 프로스타글란딘 나이트로옥시 유도체
IT1393112B1 (it) * 2009-02-27 2012-04-11 Sifavitor S R L Procedimento per la preparazione di derivati di prostaglandine
CA2777290C (en) * 2009-10-16 2016-06-28 Cayman Chemical Company, Incorporated Process for the preparation of f-series prostaglandins
WO2011055377A1 (en) 2009-11-05 2011-05-12 Biocon Limited A novel process for the preparation of prostaglandins and intermediates thereof
EP2495235B1 (en) 2011-03-04 2015-08-05 Newchem S.p.A. Process for the synthesis of prostaglandins and intermediates thereof
PL2723714T3 (pl) 2011-06-02 2018-02-28 CHINOIN Zrt. Nowe sposoby otrzymywania amidów prostaglandyn

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1533385A (zh) * 2001-05-24 2004-09-29 Ӣ��ʯ�ͻ�ѧƷ���޹�˾ 前列腺素及其类似物的制备方法
EP2143712A1 (en) * 2008-07-10 2010-01-13 Sandoz AG Improved Process for the Production of Prostaglandins and Prostaglandin Analogs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
diastereoselective reduction of the enone intermediate of travoprost;C.Aswathanarayanappa 等;《Organic process research & development》;20110815;第15卷;第1085-1087页 *

Also Published As

Publication number Publication date
WO2013093528A1 (en) 2013-06-27
RU2014129492A (ru) 2016-02-10
RU2631316C2 (ru) 2017-09-21
US20140343299A1 (en) 2014-11-20
US9212125B2 (en) 2015-12-15
IL232625B (en) 2019-03-31
MX2014007684A (es) 2014-07-28
EP2802562B1 (en) 2019-01-23
EP2802562A1 (en) 2014-11-19
JP2015506343A (ja) 2015-03-02
CA2859923A1 (en) 2013-06-27
CN103998423A (zh) 2014-08-20
HU231203B1 (hu) 2021-10-28
HK1198584A1 (en) 2015-04-30
BR112014014060A2 (pt) 2017-06-13
KR20140107541A (ko) 2014-09-04
IN2014CN03482A (enExample) 2015-07-03
JP6174040B2 (ja) 2017-08-02
ZA201404440B (en) 2015-12-23
US20160137621A1 (en) 2016-05-19
TWI640500B (zh) 2018-11-11
HUP1100701A2 (en) 2013-07-29
TR201905687T4 (tr) 2019-05-21
CA2859923C (en) 2020-11-24
ES2721662T3 (es) 2019-08-02
IL232625A0 (en) 2014-06-30
TW201336816A (zh) 2013-09-16
KR102027889B1 (ko) 2019-10-04
PL2802562T3 (pl) 2019-08-30

Similar Documents

Publication Publication Date Title
CN103998423B (zh) 曲伏前列素的制备方法
TWI738687B (zh) 製備卡前列素氨丁三醇之新穎方法
CN102056887A (zh) 前列腺素类似物和其中间体的制备方法
US20150011755A1 (en) Amine salts of prostaglandin analogs
IL134241A (en) Process for the preparation of latanoprost
JP2025160437A (ja) イロプロストの製造のための方法
WO2010109476A2 (en) Improved process for the preparation of prostaglandins and analogues thereof
EP1886992A1 (en) Method for preparing prostaglandin derivative
CN111777538A (zh) 贝美前列素的制备方法
CN104507949B (zh) 高纯度的含氮杂环化合物的制造方法
CN108084073B (zh) 一种纯化贝美前列素的方法
KR102436114B1 (ko) 신규한 이노토디올의 제조방법
WO2014094511A1 (zh) 一种制备曲前列尼尔的中间体、其制备方法以及通过其制备曲前列尼尔的方法
US20030004368A1 (en) Novel intermediate for the synthesis of prostaglandins
CN105985370B (zh) 制备利马前列腺素的关键中间体及其应用
US7642370B2 (en) Method for preparing prostaglandin derivative
HK1198584B (en) Process for the preparation of travoprost
CN114685511A (zh) 一种瑞德西韦中间体的纯化方法
TWI792440B (zh) 製備拉坦前列烯布諾德(latanoprostene bunod)之方法及其中間物與包含其之組合物
CN114685554A (zh) 一种4aa非对映异构体的制备方法
CN117843599A (zh) 一种含有1-烷基-1-烯基乙醇结构的前列腺素中间体的制备方法
KR20250050531A (ko) 타플루프로스트의 제조방법
JP4510300B2 (ja) プロスタグランジンの合成のための新規中間体
KR20210120285A (ko) 신규한 이노토디올의 제조방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant